mTOR-Controlled Autophagy Requires Intracellular Ca(2+) Signaling

PLoS One. 2013;8(4):e61020. doi: 10.1371/journal.pone.0061020. Epub 2013 Apr 2.

Abstract

Autophagy is a lysosomal degradation pathway important for cellular homeostasis and survival. Inhibition of the mammalian target of rapamycin (mTOR) is the best known trigger for autophagy stimulation. In addition, intracellular Ca(2+) regulates autophagy, but its exact role remains ambiguous. Here, we report that the mTOR inhibitor rapamycin, while enhancing autophagy, also remodeled the intracellular Ca(2+)-signaling machinery. These alterations include a) an increase in the endoplasmic-reticulum (ER) Ca(2+)-store content, b) a decrease in the ER Ca(2+)-leak rate, and c) an increased Ca(2+) release through the inositol 1,4,5-trisphosphate receptors (IP3Rs), the main ER-resident Ca(2+)-release channels. Importantly, buffering cytosolic Ca(2+) with BAPTA impeded rapamycin-induced autophagy. These results reveal intracellular Ca(2+) signaling as a crucial component in the canonical mTOR-dependent autophagy pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autophagy / drug effects
  • Calcium / metabolism
  • Calcium Signaling / drug effects
  • Calcium Signaling / genetics
  • HeLa Cells
  • Humans
  • Sirolimus / pharmacology
  • TOR Serine-Threonine Kinases / genetics
  • TOR Serine-Threonine Kinases / metabolism*

Substances

  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Calcium
  • Sirolimus

Grants and funding

This research has been funded by Grant GOA/09/12 and OT START1/10/044 from the Research Council of the K.U. Leuven, by grant G.0731.09 and G063413N from the Research Foundation Flanders (FWO), and the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office (IAP P6/28 and P7/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.